GLP-1 medications such as Ozempic and Wegovy appear to make people feel less drunk and reduce alcohol cravings by delaying ...

Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving. (HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in ...

Semaglutide could help people drink less alcohol. Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help people drink less alcohol. A ...

Semaglutide and liraglutide also linked to reduction in risks for SUD hospitalization, somatic hospitalizations. (HealthDay News) — Semaglutide and liraglutide are associated with a reduced risk for ...

2/20/25 (LAPost.com) — New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption. The study, published in JAMA ...

Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research. The study was small — just 48 adults — and lasted just ...

New research suggests GLP-1 medications like Ozempic may alter alcohol absorption, leading to a "Ozempic sober" effect where ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in ...

Clinical Director of the National Institute of Drug Abuse Dr. Lorenzo Leggio, said GLP-1 drugs' effect on the brain can help ...

Approximately 178,000 people die from excessive drinking each year. But researchers say popular weight loss drugs could help ...

Bloomberg: Rong Xu, professor at the School of Medicine, discussed recent research that links semaglutide—the key ingredient in diabetes shot Ozempic and its sister drug Wegovy for obesity—to a ...